Scott Fidel
Stock Analyst at Stephens & Co.
(1.12)
# 3,850
Out of 4,944 analysts
184
Total ratings
40%
Success rate
-3.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Reiterates: Overweight | $21 | $12.67 | +65.75% | 5 | May 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $116.56 | +21.83% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $26.08 | +45.71% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $100.98 | +0.02% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $178.51 | +24.92% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $14.76 | +15.18% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $27.07 | +169.67% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $271.81 | +148.34% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $11.48 | +170.03% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $287.10 | +42.81% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $166.27 | +0.44% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $23.55 | -10.83% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $281.99 | -11.34% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $294.43 | +108.88% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $119.13 | -11.86% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $161.21 | +98.50% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $171.87 | -29.02% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $20.77 | +343.05% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $390.46 | -28.29% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $2.25 | +4,122.22% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $7.15 | -79.02% | 3 | Nov 11, 2022 |
Ardent Health
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $12.67
Upside: +65.75%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $116.56
Upside: +21.83%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $26.08
Upside: +45.71%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $100.98
Upside: +0.02%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $178.51
Upside: +24.92%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $14.76
Upside: +15.18%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $27.07
Upside: +169.67%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $271.81
Upside: +148.34%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $11.48
Upside: +170.03%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $287.10
Upside: +42.81%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $166.27
Upside: +0.44%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $23.55
Upside: -10.83%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $281.99
Upside: -11.34%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $294.43
Upside: +108.88%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $119.13
Upside: -11.86%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $161.21
Upside: +98.50%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $171.87
Upside: -29.02%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $20.77
Upside: +343.05%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $390.46
Upside: -28.29%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $2.25
Upside: +4,122.22%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $7.15
Upside: -79.02%